Nicole Lawrence
The University of Queensland, QLD, Australia
- This delegate is presenting an abstract at this event.

My research focuses on using host defence molecules as the basis for designing peptide-based drugs with improved safety and reduced likelihood of drug resistance to combat infectious disease caused by pathogenic bacteria and malaria parasites. Zooming in to investigate molecular interactions at the cell surface and inside infected cells allows me to describe and refine how drug candidates overcome disease organisms to produce the next generation of antimicrobial drugs.
Presentations this author is a contributor to:
Development of cyclic-peptide scaffolds to target intracellular protein-protein interactions in cancer cells (#120)
8:00 PM
Gregoire Philippe
Poster Session 1
Spider toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel NaV1.7 (#137)
8:00 PM
Akello J Agwa
Poster Session 2
Tachyplesin I – hairpin peptide with anticancer properties (#131)
8:00 PM
Felicitas Vernen
Poster Session 1
Cyclic peptides designed from human platelet factor 4 selectively enter infected red blood cells and kill malaria parasites (#165)
5:04 PM
Nicole Lawrence
Session 4 - Rapid Fire Topics
Inhibitory effects of substrate-based BCR-ABL1 kinase inhibitors on drug-resistant chronic myeloid leukaemia cell lines (#155)
8:00 PM
Yen-Hua Huang
Poster Session 2